Abbott, LGC Team on MDx Biosensor Applications | GenomeWeb

NEW YORK (GenomeWeb News) – British science services firm LGC today said that it has licensed Abbott's Ibis T5000 Biosensor System and will work with Abbott to develop commercial applications for the molecular diagnostics platform.

Under terms of the alliance, the partners will jointly identify and develop commercial diagnostic applications for the T5000, which is currently sold for research uses. LGC received an exclusive license to develop non-clinical applications in the UK and a non-exclusive license to develop clinical and food-testing applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.